Advanced Glycation End Products (AGEs) and their Receptor (RAGE) System in Diabetic Retinopathy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|3|1|83-88

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.3, Iss.1, 2006-03, pp. : 83-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 362-368

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 962-968

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products and Diabetic Retinopathy

By  

Current Medicinal Chemistry, Vol. 20, Iss. 26, 2013-09 ,pp. : 3234-3240

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System

By  

Current Pharmaceutical Design, Vol. 23, Iss. 8, 2017-04 ,pp. : 1135-1141

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Advanced Glycation End Products (AGEs) and their Receptor (RAGE) in Health and Disease Executive Editor: Sho-ichi Yamagishi ]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 939-939

Bentham Science Publishers

Access to resources Recommend Favorite